×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SAVA – cassava sciences, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SAVA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/24
12:45 pm
sava
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAVA
12/24
07:15 am
sava
Investors in Cassava Sciences, Inc. Should Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your Rights - SAVA
Low
Report
Investors in Cassava Sciences, Inc. Should Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your Rights - SAVA
12/24
07:00 am
sava
SAVA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
Medium
Report
SAVA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
12/24
07:00 am
sava
SAVA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!
Medium
Report
SAVA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!
12/23
09:15 pm
sava
Levi & Korsinsky Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025 – SAVA
Low
Report
Levi & Korsinsky Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025 – SAVA
12/23
09:00 pm
sava
CASSAVA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Cassava Sciences, Inc and Encourages Investors to Contact the Firm
Low
Report
CASSAVA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Cassava Sciences, Inc and Encourages Investors to Contact the Firm
12/23
08:45 pm
sava
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 10, 2025 in Cassava Sciences, Inc. Lawsuit – SAVA
Low
Report
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 10, 2025 in Cassava Sciences, Inc. Lawsuit – SAVA
12/23
08:30 pm
sava
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines – SAVA
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines – SAVA
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
12/3
04:18 pm
sava
Form 4 CASSAVA SCIENCES INC For: Nov 29 Filed by: Kupiec James William
High
Report
Form 4 CASSAVA SCIENCES INC For: Nov 29 Filed by: Kupiec James William
12/3
04:16 pm
sava
Form 4 CASSAVA SCIENCES INC For: Nov 29 Filed by: Schoen Eric
High
Report
Form 4 CASSAVA SCIENCES INC For: Nov 29 Filed by: Schoen Eric
12/2
05:14 pm
sava
Form 144 CASSAVA SCIENCES INC Filed by: Schoen Eric
Low
Report
Form 144 CASSAVA SCIENCES INC Filed by: Schoen Eric
11/29
03:34 pm
sava
Form 144 CASSAVA SCIENCES INC Filed by: Schoen Eric
Neutral
Report
Form 144 CASSAVA SCIENCES INC Filed by: Schoen Eric
11/26
04:55 pm
sava
Form SCHEDULE 13G/A CASSAVA SCIENCES INC Filed by: Nachtrab Matthew
Medium
Report
Form SCHEDULE 13G/A CASSAVA SCIENCES INC Filed by: Nachtrab Matthew
11/20
04:39 pm
sava
Form 4 CASSAVA SCIENCES INC For: Nov 18 Filed by: Landen Jaren
High
Report
Form 4 CASSAVA SCIENCES INC For: Nov 18 Filed by: Landen Jaren
11/20
04:37 pm
sava
Form 3 CASSAVA SCIENCES INC For: Nov 18 Filed by: Landen Jaren
High
Report
Form 3 CASSAVA SCIENCES INC For: Nov 18 Filed by: Landen Jaren
11/20
04:35 pm
sava
Form 4 CASSAVA SCIENCES INC For: Nov 18 Filed by: Nassif Freda
High
Report
Form 4 CASSAVA SCIENCES INC For: Nov 18 Filed by: Nassif Freda
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
12/20
Form 4 CASSAVA SCIENCES INC For: Dec 20 Filed by: ROBERTSON SANFORD
60.3%
12/31 Form 4 CASSAVA SCIENCES INC For: Dec 31 Filed by: BARBIER REMI 37.1%
4/23 Cassava Sciences Announces New $2.5 Million Research Grant Award from National Institutes of Health 32.9%
12/26 Form 4/A CASSAVA SCIENCES INC For: Dec 18 Filed by: BARBIER REMI 29.3%
1/28 Cassava Sciences Announces Completion of Patient Enrollment of a Phase 2b Study in Alzheimer’s Disease 20.8%
9/3 Cassava Sciences to Present at H.C. Wainwright’s 21st Annual Global Investment Conference 17.9%
12/19 Form 4 CASSAVA SCIENCES INC For: Dec 19 Filed by: ROBERTSON SANFORD 17.5%
3/19 Cassava Sciences Announces Clinical Update and Business Progress Across Neuroscience Pipeline 17.2%
4/9 Form S-3/A CASSAVA SCIENCES INC 16.5%
1/15 Cassava Sciences Inc (NASDAQ: SAVA) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. 14.5%
12/31 Form 4 CASSAVA SCIENCES INC For: Dec 31 Filed by: BARBIER REMI 37.1%
4/23 Cassava Sciences Announces New $2.5 Million Research Grant Award from National Institutes of Health 32.9%
12/26 Form 4/A CASSAVA SCIENCES INC For: Dec 18 Filed by: BARBIER REMI 29.3%
1/28 Cassava Sciences Announces Completion of Patient Enrollment of a Phase 2b Study in Alzheimer’s Disease 20.8%
9/3 Cassava Sciences to Present at H.C. Wainwright’s 21st Annual Global Investment Conference 17.9%
12/19 Form 4 CASSAVA SCIENCES INC For: Dec 19 Filed by: ROBERTSON SANFORD 17.5%
3/19 Cassava Sciences Announces Clinical Update and Business Progress Across Neuroscience Pipeline 17.2%
4/9 Form S-3/A CASSAVA SCIENCES INC 16.5%
1/15 Cassava Sciences Inc (NASDAQ: SAVA) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. 14.5%
TOP News Decliners
12/6
Cassava Sciences Inc (NASDAQ: SAVA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock, up previously from $3.00.
-21.8%
9/9 Cassava Sciences Reports Positive Phase 2a Clinical Results in Alzheimer’s Patients -15.9%
1/6 Are Insiders Buying Cassava Sciences, Inc. (NASDAQ:SAVA) Stock? [Yahoo! Finance News] -9.6%
1/7 Form SC 13G/A CASSAVA SCIENCES INC Filed by: HIRSCHMAN ORIN -9.4%
6/25 Cassava Sciences Inc (NASDAQ: SAVA) is now covered by analysts at Maxim Group. They set a "buy" rating on the stock. -8.5%
1/24 Cassava Sciences Inc (NASDAQ: SAVA) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $9.00 price target on the stock. -8.0%
8/1 Cassava Sciences Inc (NASDAQ: SAVA) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $3.00 price target on the stock. -7.6%
8/12 Q2/2019 6/30/2019 EPS -0.060 ZacksConsensus -0.120 ActVsEst 0.060 - Beat -6.8%
3/27 Form S-3 CASSAVA SCIENCES INC -5.2%
10/19 Cassava Sciences Inc (NASDAQ: SAVA) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -4.8%
9/9 Cassava Sciences Reports Positive Phase 2a Clinical Results in Alzheimer’s Patients -15.9%
1/6 Are Insiders Buying Cassava Sciences, Inc. (NASDAQ:SAVA) Stock? [Yahoo! Finance News] -9.6%
1/7 Form SC 13G/A CASSAVA SCIENCES INC Filed by: HIRSCHMAN ORIN -9.4%
6/25 Cassava Sciences Inc (NASDAQ: SAVA) is now covered by analysts at Maxim Group. They set a "buy" rating on the stock. -8.5%
1/24 Cassava Sciences Inc (NASDAQ: SAVA) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $9.00 price target on the stock. -8.0%
8/1 Cassava Sciences Inc (NASDAQ: SAVA) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $3.00 price target on the stock. -7.6%
8/12 Q2/2019 6/30/2019 EPS -0.060 ZacksConsensus -0.120 ActVsEst 0.060 - Beat -6.8%
3/27 Form S-3 CASSAVA SCIENCES INC -5.2%
10/19 Cassava Sciences Inc (NASDAQ: SAVA) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -4.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: